MRUS Competitors & Alternatives
Compare Merus BV with similar stocks in the same industry
Biotechnology
MRUS
Main Stock$90.00
Tradestie Score
55
Market Cap
$7.14B
Revenue Growth
0.0%
Analyst Upside
+7.8%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
HALO
Halozyme Therapeutics, Inc.
|
$79.45
|
$8.77B | 27.0 | 61 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$189.24
|
$8.57B | - | 62 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$18.30
|
$8.53B | - | 62 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$243.47
|
$8.30B | 1979.3 | 61 | Compare |
|
CYTK
Cytokinetics Inc.
|
$86.49
|
$6.68B | - | 64 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$114.17
|
$6.64B | - | 54 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$144.65
|
$6.38B | - | 59 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$29.91
|
$6.03B | - | 51 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$60.08
|
$6.02B | - | 63 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.73
|
$5.95B | - | 61 | Compare |
More MRUS Analysis
Data updated: Jul 03, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry